Veradigm | MDRX - Ebit

Stock Price
4.31
Daily Change
-0.19 -4.22%
Monthly
-6.30%
Yearly
-15.49%
Q1 Forecast
7.75

Veradigm reported $25M in EBIT for its fiscal quarter ending in September of 2022.





Ebit Change Date
Alcidion AUD 444K 1.36M Jun/2025
Ambu A/S DKK 168M 21M Dec/2025
Amplifon EUR 26.28M 39.26M Sep/2025
Cardinal Health USD 763M 9M Dec/2025
Centene USD -1.23B 1.03B Dec/2025
Charles River Laboratories USD 75.82M 57.98M Dec/2025
Cigna USD 2.58B 220M Sep/2025
Convatec Group USD 262.5M 39.7M Dec/2024
CVS Health USD 2.11B 836M Dec/2025
Diasorin EUR 56.68M 13.53M Sep/2025
Elevance Health USD 581M 1.18B Dec/2025
General Electric Aerospace USD 1.68B 429M Dec/2025
Gulf Medical Proj AED 14.11M 2.06M Sep/2023
Humana USD -808M 1.21B Dec/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Laboratory Of America USD 382M 11M Dec/2025
Maximus USD 146.21M 23.31M Dec/2025
McKesson USD 1.66B 159M Dec/2025
Med Life RON 40.09M 34.8M Sep/2025
Molina Healthcare USD -153M 293M Dec/2025
Omnicell USD 1.18M 9.81M Dec/2025
Oriola-kd EUR 6.6M 1.6M Sep/2025
Owens Minor USD 61.29M 34.09M Mar/2025
Quest Diagnostics USD 386M 0 Dec/2025
Rede D'or Sao Luiz BRL 2.79B 2.16B Sep/2025
Siemens Healthineers EUR 677M 214M Dec/2025
Sonova Holding CHF 296.8M 156.9M Dec/2025
Supermax Corporation Bhd MYR -143.15M 38.31M Sep/2025
UnitedHealth USD 3.26B 1.06B Dec/2025
Veeva Systems USD 240.85M 14.32M Sep/2025
Veradigm USD 25M 30.16M Sep/2022
Xerox USD 30M 8M Jun/2025